Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Arcoxia 90mg Tablet – PA1997/001/003
- Cozatan Comp 50mg/12.5mg Film Coated Tablet – PA0126/184/001
- Duac Once Daily 10mg/g + 50mg/g Gel – PA1077/120/001
- Erythroped 125mg/5ml Granules for Oral Suspension – PA1142/006/002
- Esbriet 267mg Film Coated Tablet – EU/1/11/667/005/008
- Livial 2.5mg Tablet – PA1286/059/001
- Mefac 250mg Capsule – PA0074/015/001
- Methotrexate 5mg/2ml Injection – PA0822/206/001
- Neoclarityn 0.5mg/ml Oral Solution (150ml presentation) – EU/1/00/161/067
- Notiabolfen XL 150mg Prolonged Release Tablet – PA2315/066/005
- Ramitace 2.5mg Tablet – PA0126/163/001
- Ramitace 10mg Tablet – PA0126/163/003
- Targin 80mg/40mg Prolonged Release Tablet – PA1688/010/009
- Trandate 100mg Film Coated Tablet – PA1638/006/002
- Trandate 200mg Film Coated Tablet – PA1638/006/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Cardura 2mg Tablet – PA0822/192/002
- Neoclarityn 5mg Tablet – EU/1/00/161/011
- Salamol Steri-Neb 5mg/2.5ml Nebuliser Solution – PA1986/086/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.